GTBP
GT Biopharma·NASDAQ
--
--(--)
--
--(--)
GTBP fundamentals
GT Biopharma (GTBP) released its earnings on Aug 14, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.55 (YoY +74.65%), beat estimates.
Revenue / YoY
0
--
EPS / YoY
-0.55
+74.65%
Report date
Aug 14, 2025
EPS
Actual | -49.65 | -54.9 | -4.5 | -5.8744 | -16.95 | -5.1 | -3 | -6.6 | -5.4 | -0.3 | -1.6505 | -1.8 | -1.64 | -2.17 | -1.53 | -1.67 | -0.33 | -0.55 | |
Forecast | -3.45 | -7.35 | -8.3 | -4.7 | -5.9 | -9.3 | -5.25 | -3.3 | -5.25 | -4.35 | -3 | -2.55 | -2.7 | -2.7 | -2.7 | -2.7 | -1.55 | -0.33 | -0.68 |
Surprise | -1339.13% | -646.94% | +45.78% | -24.99% | -187.29% | +45.16% | +42.86% | -100.00% | -2.86% | +93.10% | +44.98% | +29.41% | 0.00% | +39.26% | +19.63% | +43.33% | -7.74% | 0.00% | +19.12% |
Revenue
Actual | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -- | -- | -- | -- | -- | -- | -- | -- | 0 | 0 | 0 | 0 |
Forecast | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -- | -- | -- | 0 | 0 | 0 |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings Call
You can ask Aime
What is the revenue and EPS growth rate for GT Biopharma year over year?What were the key takeaways from GT Biopharma’s earnings call?What is GT Biopharma's latest dividend and current dividend yield?What guidance did GT Biopharma's management provide for the next earnings period?What does GT Biopharma do and what are its main business segments?Did GT Biopharma beat or miss consensus estimates last quarter?What were the key takeaways from GT Biopharma's earnings call?What is the market's earnings forecast for GT Biopharma next quarter?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
